Pathogenic CD8+ T cells in experimental cerebral malaria

Seminars in Immunopathology

Volumn 37, Issue 3, 2015, Pages 221-231

  Howland, Shanshan Wu ^a   Claser, Carla ^a   Poh, Chek Meng ^a,b   Gun, Sin Yee ^a,b   Rénia, Laurent ^a,b  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Brain; CD8+ T cells; Malaria; Pathology

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CXCL11 CHEMOKINE; CXCL4 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; UNCLASSIFIED DRUG; EPITOPE;

BIOLOGICAL ACTIVITY; BRAIN MALARIA; CD8+ T LYMPHOCYTE; DENDRITIC CELL; DISEASE COURSE; EFFECTOR CELL; EXPERIMENTAL CEREBRAL MALARIA; HUMAN; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PRIMING; MOLECULAR PATHOLOGY; NEGATIVE REGULATION; NONHUMAN; PHENOTYPIC VARIATION; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPLEEN; ANIMAL; CELL MOTION; CEREBRAL MALARIA; CHEMISTRY; CYTOTOXICITY; DISEASE MODEL; EXTRACELLULAR MATRIX; HOST PARASITE INTERACTION; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; PARASITOLOGY; PHENOTYPE; PLASMODIUM;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; EPITOPES, T-LYMPHOCYTE; EXTRACELLULAR MATRIX; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNOMODULATION; MALARIA, CEREBRAL; PHENOTYPE; PLASMODIUM;

EID: 84929840773     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-015-0476-6     Document Type: Review

References (86)

1. White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM (2014) Malaria. Lancet 383(9918):723–735. doi:10.1016/S0140-6736(13)60024-0
2. Smith JD (2014) The role of PfEMP1 adhesion domain classification in Plasmodium falciparum pathogenesis research. Mol Biochem Parasitol 195(2):82–87. doi:10.1016/j.molbiopara.2014.07.006
3. MacPherson GG, Warrell MJ, White NJ, Looareesuwan S, Warrell DA (1985) Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol 119(3):385–401
4. Lavstsen T, Turner L, Saguti F, Magistrado P, Rask TS, Jespersen JS, Wang CW, Berger SS, Baraka V, Marquard AM, Seguin-Orlando A, Willerslev E, Gilbert MT, Lusingu J, Theander TG (2012) Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children. Proc Natl Acad Sci U S A 109(26):E1791–1800. doi:10.1073/pnas.1120455109
5. Avril M, Tripathi AK, Brazier AJ, Andisi C, Janes JH, Soma VL, Sullivan DJ Jr, Bull PC, Stins MF, Smith JD (2012) A restricted subset of var genes mediates adherence of Plasmodium falciparum-infected erythrocytes to brain endothelial cells. Proc Natl Acad Sci U S A 109(26):E1782–1790. doi:10.1073/pnas.1120534109
6. Claessens A, Adams Y, Ghumra A, Lindergard G, Buchan CC, Andisi C, Bull PC, Mok S, Gupta AP, Wang CW, Turner L, Arman M, Raza A, Bozdech Z, Rowe JA (2012) A subset of group a-like var genes encodes the malaria parasite ligands for binding to human brain endothelial cells. Proc Natl Acad Sci U S A 109(26):E1772–1781. doi:10.1073/pnas.1120461109
7. Turner L, Lavstsen T, Berger SS, Wang CW, Petersen JE, Avril M, Brazier AJ, Freeth J, Jespersen JS, Nielsen MA, Magistrado P, Lusingu J, Smith JD, Higgins MK, Theander TG (2013) Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature 498(7455):502–505. doi:10.1038/nature12216
8. Engwerda C, Belnoue E, Gruner AC, Renia L (2005) Experimental models of cerebral malaria. Curr Top Microbiol Immunol 297:103–143
9. Renia L, Potter SM, Mauduit M, Rosa DS, Kayibanda M, Deschemin JC, Snounou G, Gruner AC (2006) Pathogenic T cells in cerebral malaria. Int J Parasitol 36(5):547–554. doi:10.1016/j.ijpara.2006.02.007
10. + T cells induced by sporozoites and those induced by blood-stage Plasmodium berghei ANKA involved in the development of cerebral malaria. Infect Immun 72(5):2817–2826. doi:10.1128/iai. 72.5.2817-2826.2004
11. + T cells in experimental cerebral malaria. J Immunol 169(11):6369–6375
12. + dendritic cells. Proc Natl Acad Sci U S A 105(38):14509–14514. doi:10.1073/pnas.0806727105
13. + T cells during blood stage of Plasmodium berghei infection. J Immunol 181(2):1420–1428
14. + T-cell response despite residence largely in cells lacking MHC I processing machinery. J Infect Dis 204(12):1989–1996. doi:10.1093/infdis/jir656
15. + T cells from a novel T cell receptor transgenic mouse induce liver-stage immunity that can be boosted by blood-stage infection in rodent malaria. PLoS Pathog 10(5):e1004135. doi:10.1371/journal.ppat.1004135
16. Howland SW, Poh CM, Gun SY, Claser C, Malleret B, Shastri N, Ginhoux F, Grotenbreg GM, Renia L (2013) Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria. EMBO Mol Med 5(7):916–931. doi:10.1002/emmm.201202273
17. + T cells with different specificities. Infect Immun 82(11):4854–4864. doi:10.1128/IAI. 02180-14
18. Lin JW, Shaw TN, Annoura T, Fougere A, Bouchier P, Chevalley-Maurel S, Kroeze H, Franke-Fayard B, Janse CJ, Couper KN, Khan SM (2014) The subcellular location of ovalbumin in Plasmodium berghei blood stages influences the magnitude of T-cell responses. Infect Immun 82(11):4654–4665. doi:10.1128/IAI. 01940-14
19. + T cells is required for the development of experimental cerebral malaria. J Immunol 186(11):6148–6156
20. + T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol 170(4):2221–2228
21. Engwerda CR, Beattie L, Amante FH (2005) The importance of the spleen in malaria. Trends Parasitol 21(2):75–80. doi:10.1016/j.pt.2004.11.008
22. + T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development. J Immunol 143(6):2017–2023
23. Yap GS, Stevenson MM (1994) Differential requirements for an intact spleen in induction and expression of B-cell-dependent immunity to Plasmodium chabaudi AS. Infect Immun 62(10):4219–4225
24. Sayles PC, Yanez DM, Wassom DL (1993) Plasmodium yoelii: splenectomy alters the antibody responses of infected mice. Exp Parasitol 76(4):377–384. doi:10.1006/expr.1993.1046
25. Amante FH, Haque A, Stanley AC, Rivera Fde L, Randall LM, Wilson YA, Yeo G, Pieper C, Crabb BS, de Koning-Ward TF, Lundie RJ, Good MF, Pinzon-Charry A, Pearson MS, Duke MG, McManus DP, Loukas A, Hill GR, Engwerda CR (2010) Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol 185(6):3632–3642. doi:10.4049/jimmunol.1000944
26. Tamura T, Kimura K, Yuda M, Yui K (2011) Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA. Infect Immun 79(10):3947–3956. doi:10.1128/IAI. 01337-10
27. Guermonprez P, Helft J, Claser C, Deroubaix S, Karanje H, Gazumyan A, Darasse-Jeze G, Telerman SB, Breton G, Schreiber HA, Frias-Staheli N, Billerbeck E, Dorner M, Rice CM, Ploss A, Klein F, Swiecki M, Colonna M, Kamphorst AO, Meredith M, Niec R, Takacs C, Mikhail F, Hari A, Bosque D, Eisenreich T, Merad M, Shi Y, Ginhoux F, Renia L, Urban BC, Nussenzweig MC (2013) Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat Med 19(6):730–738. doi:10.1038/nm.3197
28. + dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to Plasmodium chabaudi malaria. Int J Parasitol 40(6):711–719. doi:10.1016/j.ijpara.2009.11.005
29. Wykes MN, Kay JG, Manderson A, Liu XQ, Brown DL, Richard DJ, Wipasa J, Jiang SH, Jones MK, Janse CJ, Waters AP, Pierce SK, Miller LH, Stow JL, Good MF (2011) Rodent blood-stage Plasmodium survive in dendritic cells that infect naive mice. Proc Natl Acad Sci U S A 108(27):11205–11210. doi:10.1073/pnas.1108579108
30. deWalick S, Amante FH, McSweeney KA, Randall LM, Stanley AC, Haque A, Kuns RD, MacDonald KP, Hill GR, Engwerda CR (2007) Cutting edge: conventional dendritic cells are the critical APC required for the induction of experimental cerebral malaria. J Immunol 178(10):6033–6037
31. Lundie RJ, Young LJ, Davey GM, Villadangos JA, Carbone FR, Heath WR, Crabb BS (2010) Blood-stage Plasmodium berghei infection leads to short-lived parasite-associated antigen presentation by dendritic cells. Eur J Immunol 40(6):1674–1681. doi:10.1002/eji.200939265
32. + dendritic cells mediate the development of experimental cerebral malaria. J Immunol 189(3):1128–1132. doi:10.4049/jimmunol.1201171
33. Hanum PS, Hayano M, Kojima S (2003) Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. Int Immunol 15(5):633–640. doi:10.1093/intimm/dxg065
34. Hansen DS, Evans KJ, D’Ombrain MC, Bernard NJ, Sexton AC, Buckingham L, Scalzo AA, Schofield L (2005) The natural killer complex regulates severe malarial pathogenesis and influences acquired immune responses to Plasmodium berghei ANKA. Infect Immun 73(4):2288–2297
35. Lovegrove FE, Pena-Castillo L, Mohammad N, Liles WC, Hughes TR, Kain KC (2006) Simultaneous host and parasite expression profiling identifies tissue-specific transcriptional programs associated with susceptibility or resistance to experimental cerebral malaria. BMC Genomics 7:295
36. Lovegrove FE, Gharib SA, Patel SN, Hawkes CA, Kain KC, Liles WC (2007) Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria. Am J Pathol 171(6):1894–1903. doi:10.2353/ajpath.2007.070630
37. Delahaye N, Coltel N, Puthier D, Barbier M, Benech P, Joly F, Iraqi F, Grau G, Nguyen C, Rihet P (2007) Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice. BMC Genomics 8(1):1–16. doi:10.1186/1471-2164-8-452
38. Miu J, Mitchell AJ, Muller M, Carter SL, Manders PM, McQuillan JA, Saunders BM, Ball HJ, Lu B, Campbell IL, Hunt NH (2008) Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J Immunol 180(2):1217–1230
39. Miu J, Hunt NH, Ball HJ (2008) Predominance of interferon-related responses in the brain during murine malaria, as identified by microarray analysis. Infect Immun 76(5):1812–1824
40. Oakley MS, McCutchan TF, Anantharaman V, Ward JM, Faucette L, Erexson C, Mahajan B, Zheng H, Majam V, Aravind L, Kumar S (2008) Host biomarkers and biological pathways that are associated with the expression of experimental cerebral malaria in mice. Infect Immun 76(10):4518–4529
41. Belnoue E, Kayibanda M, Deschemin JC, Viguier M, Mack M, Kuziel WA, Renia L (2003) CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood 101(11):4253–4259
42. Belnoue E, Costa FT, Vigario AM, Voza T, Gonnet F, Landau I, Van Rooijen N, Mack M, Kuziel WA, Renia L (2003) Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria. Infect Immun 71(6):3648–3651
43. + T cells to the brain during Plasmodium berghei-mediated cerebral malaria. J Immunol 178(9):5779–5788
44. Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA, Colvin RA, Luster AD (2008) Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci U S A 105(12):4814–4819
45. Van den Steen PE, Deroost K, Van Aelst I, Geurts N, Martens E, Struyf S, Nie CQ, Hansen DS, Matthys P, Van Damme J, Opdenakker G (2008) CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines. Eur J Immunol 38(4):1082–1095
46. Nie CQ, Bernard NJ, Norman MU, Amante FH, Lundie RJ, Crabb BS, Heath WR, Engwerda CR, Hickey MJ, Schofield L, Hansen DS (2009) IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog 5(4):e1000369. doi:10.1371/journal.ppat.1000369
47. Wilson NO, Solomon W, Anderson L, Patrickson J, Pitts S, Bond V, Liu M, Stiles JK (2013) Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria. PLoS One 8(4):e60898. doi:10.1371/journal.pone.0060898
48. Srivastava K, Cockburn IA, Swaim A, Thompson LE, Tripathi A, Fletcher CA, Shirk EM, Sun H, Kowalska MA, Fox-Talbot K, Sullivan D, Zavala F, Morrell CN (2008) Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host Microbe 4(2):179–187. doi:10.1016/j.chom.2008.07.003
49. Yanez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC (1996) Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol 157(4):1620–1624
50. Amani V, Vigário AM, Belnoue E, Marussig M, Fonseca L, Mazier D, Rénia L (2000) Involvement of IFN-γ receptor-mediated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur J Immunol 30(6):1646–1655. doi:10.1002/1521-4141(200006)30:6<1646::aid-immu1646>3.0.co;2-0
51. + T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol 30(10):544–553. doi:10.1111/j.1365-3024.2008.01053.x
52. Hunt NH, Ball HJ, Hansen AM, Khaw LT, Guo J, Bakmiwewa S, Mitchell AJ, Combes V, Grau GE (2014) Cerebral malaria: gamma-interferon redux. Front Cell Infect Microbiol 4:113. doi:10.3389/fcimb.2014.00113
53. + T cell accumulation within the brain. J Immunol 189(2):968–979
54. Hansen DS, Ryg-Cornejo V, Ioannidis LJ, Chiu CY, Ly A, Nie CQ, Scalzo AA, Schofield L (2014) The contribution of natural killer complex loci to the development of experimental cerebral malaria. PLoS One 9(4):e93268. doi:10.1371/journal.pone.0093268
55. Renia L, Howland SW, Claser C, Charlotte Gruner A, Suwanarusk R, Hui Teo T, Russell B, Ng LF (2012) Cerebral malaria: mysteries at the blood–brain barrier. Virulence 3(2):193–201. doi:10.4161/viru.19013
56. Pino P, Taoufiq Z, Nitcheu J, Vouldoukis I, Mazier D (2005) Blood–brain barrier breakdown during cerebral malaria: suicide or murder? Thromb Haemost 94(2):336–340. doi:10.1267/THRO05020336
57. Mai J, Virtue A, Shen J, Wang H, Yang XF (2013) An evolving new paradigm: endothelial cells–conditional innate immune cells. J Hematol Oncol 6:61. doi:10.1186/1756-8722-6-61
58. El-Assaad F, Wheway J, Mitchell AJ, Lou J, Hunt NH, Combes V, Grau GE (2013) Cytoadherence of Plasmodium berghei-infected red blood cells to murine brain and lung microvascular endothelial cells in vitro. Infect Immun 81(11):3984–3991. doi:10.1128/IAI. 00428-13
59. Baptista FG, Pamplona A, Pena AC, Mota MM, Pied S, Vigario AM (2010) Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect Immun 78(9):4033–4039
60. + regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23(3):287–296. doi:10.1016/j.immuni.2005.08.006
61. Jangpatarapongsa K, Chootong P, Sattabongkot J, Chotivanich K, Sirichaisinthop J, Tungpradabkul S, Hisaeda H, Troye-Blomberg M, Cui L, Udomsangpetch R (2008) Plasmodium vivax parasites alter the balance of myeloid and plasmacytoid dendritic cells and the induction of regulatory T cells. Eur J Immunol 38(10):2697–2705. doi:10.1002/eji.200838186
62. Tetsutani K, Ishiwata K, Ishida H, Tu L, Torii M, Hamano S, Himeno K, Hisaeda H (2009) Concurrent infection with heligmosomoides polygyrus suppresses anti-Plasmodium yoelii protection partially by induction of CD4(+)CD25(+)Foxp3(+) treg in mice. Eur J Immunol 39(10):2822–2830. doi:10.1002/eji.200939433
63. + T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria. Int J Parasitol 37(8–9):963–973. doi:10.1016/j.ijpara.2007.01.004
64. +) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion. Int J Parasitol 38(2):229–238. doi:10.1016/j.ijpara.2007.07.006
65. Amante FH, Stanley AC, Randall LM, Zhou Y, Haque A, McSweeney K, Waters AP, Janse CJ, Good MF, Hill GR, Engwerda CR (2007) A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am J Pathol 171(2):548–559. doi:10.2353/ajpath.2007.061033
66. + regulatory T cells in the control of experimental cerebral malaria. J Immunol 183(11):7014–7022. doi:10.4049/jimmunol.0901422
67. + natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog 6(12):e1001221. doi:10.1371/journal.ppat.1001221
68. Hafalla JC, Claser C, Couper KN, Grau GE, Renia L, de Souza JB, Riley EM (2012) The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. PLoS Pathog 8(2):e1002504. doi:10.1371/journal.ppat.1002504
69. Jacobs T, Graefe SE, Niknafs S, Gaworski I, Fleischer B (2002) Murine malaria is exacerbated by CTLA-4 blockade. J Immunol 169(5):2323–2329
70. Watanabe N, Gavrieli M, Sedy JR, Yang J, Fallarino F, Loftin SK, Hurchla MA, Zimmerman N, Sim J, Zang X, Murphy TL, Russell JH, Allison JP, Murphy KM (2003) BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 4(7):670–679. doi:10.1038/ni944
71. Lepenies B, Pfeffer K, Hurchla MA, Murphy TL, Murphy KM, Oetzel J, Fleischer B, Jacobs T (2007) Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria. J Immunol 179(6):4093–4100
72. Kossodo S, Monso C, Juillard P, Velu T, Goldman M, Grau GE (1997) Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 91(4):536–540
73. Liu Y, Chen Y, Li Z, Han Y, Sun Y, Wang Q, Liu B, Su Z (2013) Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice. Eur J Immunol 43(11):2907–2918. doi:10.1002/eji.201343512
74. Niikura M, Inoue S, Kobayashi F (2011) Role of interleukin-10 in malaria: focusing on coinfection with lethal and nonlethal murine malaria parasites. J Biomed Biotechnol 2011:383962. doi:10.1155/2011/383962
75. + cell-mediated pathology. Proc Natl Acad Sci U S A 91(17):8097–8101
76. Craig AG, Grau GE, Janse C, Kazura JW, Milner D, Barnwell JW, Turner G, Langhorne J, Participants of the Hinxton Retreat meeting on Animal Models for Research on Severe M (2012) The role of animal models for research on severe malaria. PLoS Pathog 8(2):e1002401. doi:10.1371/journal.ppat.1002401
77. + T cells and IFN-gamma mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS One 6(4):e18720. doi:10.1371/journal.pone.0018720
78. Dorovini-Zis K, Schmidt K, Huynh H, Fu W, Whitten RO, Milner D, Kamiza S, Molyneux M, Taylor TE (2011) The neuropathology of fatal cerebral malaria in Malawian children. Am J Pathol 178(5):2146–2158. doi:10.1016/j.ajpath.2011.01.016
79. Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, Anderson W, Adjei AA, Gyasi RK, Tettey Y, Wiredu EK, Tongren JE, Udhayakumar V, Stiles JK (2007) Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J 6:147. doi:10.1186/1475-2875-6-147
80. Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO, Crawford S, Joel PK, Singh MP, Nagpal AC, Dash AP, Udhayakumar V, Singh N, Stiles JK (2008) Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J 7:83. doi:10.1186/1475-2875-7-83
81. Wilson NO, Jain V, Roberts CE, Lucchi N, Joel PK, Singh MP, Nagpal AC, Dash AP, Udhayakumar V, Singh N, Stiles JK (2011) CXCL4 and CXCL10 predict risk of fatal cerebral malaria. Dis Markers 30(1):39–49. doi:10.3233/DMA-2011-0763
82. Wilson N, Driss A, Solomon W, Dickinson-Copeland C, Salifu H, Jain V, Singh N, Stiles J (2013) CXCL10 gene promoter polymorphism -1447A>G correlates with plasma CXCL10 levels and is associated with male susceptibility to cerebral malaria. PLoS One 8(12):e81329. doi:10.1371/journal.pone.0081329
83. Groom JR, Luster AD (2011) CXCR3 in T cell function. Exp Cell Res 317(5):620–631. doi:10.1016/j.yexcr.2010.12.017
84. Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, Sagrinati C, Mazzinghi B, Orlando C, Maggi E, Marra F, Romagnani S, Serio M, Romagnani P (2003) An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med 197(11):1537–1549. doi:10.1084/jem.20021897
85. Jambou R, Combes V, Jambou MJ, Weksler BB, Couraud PO, Grau GE (2010) Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions. PLoS Pathog 6(7):e1001021. doi:10.1371/journal.ppat.1001021
86. Khaw LT, Ball HJ, Golenser J, Combes V, Grau GE, Wheway J, Mitchell AJ, Hunt NH (2013) Endothelial cells potentiate interferon-gamma production in a novel tripartite culture model of human cerebral malaria. PLoS One 8(7):e69521. doi:10.1371/journal.pone.0069521